Nucleosides: Clinical Trials

2 trials of Nucleosides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow Nucleosides: new trials by email Literature Review of Nucleosides trials Research Report on Nucleosides

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance
PEG-interferon-Alfa-2A, Nucleosides - Chronic Hepatitis B
Phase 3UnknownPusan National University Hospital1442013-05-012014-11-04
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV
Atazanavir + ritonavir + tenofovir + nucleoside, Atazanavir + saquinavir + tenofovir + nucleoside, Lopinavir/ritonavir + tenofovir + nucleoside - HIV Infections
Phase 3CompletedBristol-Myers Squibb5712001-11-012010-12-24

Conditions studied

HIV Infections (1)  ·  Hepatitis B, Chronic (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Pusan National University Hospital (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Jeong Heo, Dr (1)

Results publications

PMID 35867702